maat013

Biologicalexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Oct 1, 2021 (NCT04769895)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04988841Phase 2Nov 1, 2021Assistance Publique - Hôpitaux de Paris
NCT04769895Phase 3Oct 1, 2021MaaT Pharma
NCT04768907N/AMaaT Pharma
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
MaaT PharmaFor profit2222021
Assistance Publique - Hôpitaux de ParisAcademic/Hospital1112021
2 organizations
Page 1 / 1